Smithfield Trust’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,883
| Closed | -$333K | – | 1120 |
|
|
2020
Q1 | $333K | Hold |
1,883
| – | – | 0.03% | 178 |
|
|
2019
Q4 | $360K | Sell |
1,883
-12
| -0.6% | -$2.17K | 0.03% | 194 |
|
|
2019
Q3 | $319K | Hold |
1,895
| – | – | 0.03% | 205 |
|
|
2019
Q2 | $317K | Sell |
1,895
-2,224
| -54% | -$308K | 0.03% | 205 |
|
|
2019
Q1 | $603K | Buy |
4,119
+763
| +23% | +$111K | 0.07% | 138 |
|
|
2018
Q4 | $449K | Sell |
3,356
-936
| -22% | -$153K | 0.05% | 146 |
|
|
2018
Q3 | $817K | Buy |
4,292
+347
| +9% | +$63.7K | 0.09% | 118 |
|
|
2018
Q2 | $657K | Sell |
3,945
-393
| -9% | -$63.1K | 0.08% | 130 |
|
|
2018
Q1 | $730K | Sell |
4,338
-224
| -5% | -$37.6K | 0.09% | 120 |
|
|
2017
Q4 | $746K | Sell |
4,562
-615
| -12% | -$110K | 0.09% | 125 |
|
|
2017
Q3 | $1.06M | Buy |
5,177
+134
| +3% | +$31.2K | 0.14% | 94 |
|
|
2017
Q2 | $1.23M | Sell |
5,043
-342
| -6% | -$80.4K | 0.18% | 80 |
|
|
2017
Q1 | $1.29M | Buy |
5,385
+837
| +18% | +$195K | 0.2% | 72 |
|
|
2016
Q4 | $955K | Sell |
4,548
-135
| -3% | -$28K | 0.16% | 86 |
|
|
2016
Q3 | $1.08M | Buy |
4,683
+1,900
| +68% | +$464K | 0.19% | 71 |
|
|
2016
Q2 | $643K | Buy |
2,783
+27
| +1% | +$6.22K | 0.12% | 118 |
|
|
2016
Q1 | $739K | Buy |
2,756
+32
| +1% | +$9.16K | 0.14% | 101 |
|
|
2015
Q4 | $851K | Sell |
2,724
-618
| -18% | -$184K | 0.18% | 81 |
|
|
2015
Q3 | $908K | Sell |
3,342
-27
| -0.8% | -$8.29K | 0.19% | 78 |
|
|
2015
Q2 | $1.02M | Sell |
3,369
-81
| -2% | -$24.2K | 0.2% | 77 |
|
|
2015
Q1 | $1.03M | Buy |
3,450
+79
| +2% | +$22.5K | 0.2% | 79 |
|
|
2014
Q4 | $868K | Sell |
3,371
-85
| -2% | -$21.2K | 0.18% | 92 |
|
|
2014
Q3 | $834K | Buy |
3,456
+759
| +28% | +$170K | 0.17% | 103 |
|
|
2014
Q2 | $601K | Sell |
2,697
-197
| -7% | -$40.8K | 0.12% | 136 |
|
|
2014
Q1 | $596K | Sell |
2,894
-729
| -20% | -$144K | 0.12% | 141 |
|
|
2013
Q4 | $609K | Sell |
3,623
-791
| -18% | -$124K | 0.12% | 138 |
|
|
2013
Q3 | $635K | Sell |
4,414
-480
| -10% | -$63.9K | 0.15% | 120 |
|
|
2013
Q2 | $618K | Buy |
+4,894
| New | +$554K | 0.15% | 120 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Smithfield Trust's AGN Position: Q2 2020 in Review
Smithfield Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,883 shares — an estimated $333K sold.
Smithfield Trust first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.29M in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Smithfield Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Smithfield Trust sold 1,883 Allergan plc shares in Q2 2020, an estimated $333K.
- Smithfield Trust first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Smithfield Trust's Allergan plc position peaked at $1.29M in Q1 2017.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Smithfield Trust's 13F filing for Q2 2020, filed 14 Aug 2020.